# Strategy to Improve Adherence of Roflumilast

> **NCT02018432** · PHASE4 · UNKNOWN · sponsor: **Asan Medical Center** · enrollment: 80 (estimated)

## Conditions studied

- Chronic Obstructive Pulmonary Disease

## Interventions

- **DRUG:** Roflumilast escalation dosage
- **DRUG:** Roflumilast conventional dosage

## Key facts

- **NCT ID:** NCT02018432
- **Lead sponsor:** Asan Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2013-12
- **Primary completion:** 2015-12
- **Final completion:** 2015-12
- **Target enrollment:** 80 (ESTIMATED)
- **Last updated:** 2013-12-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02018432

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02018432, "Strategy to Improve Adherence of Roflumilast". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT02018432. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*